Results 131 to 140 of about 328,619 (354)

Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic‐Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney Transplantation

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Alemtuzumab is a T cell‐depleting monoclonal antibody that is used for the prevention of kidney transplant rejection. The duration of lymphodepletion after the current standard induction therapy dose is likely longer than necessary, resulting in prolonged T cell lymphopenia with the associated risk of infections. Here, the interplay between alemtuzumab
Lukas K. van Vugt   +8 more
wiley   +1 more source

СТРАНИЦЫ ИСТОРИИ НЕФРОЛОГИИ ДОНА ПЕРВОЙ ПОЛОВИНЫ XX ВЕКА

open access: yesАрхивъ внутренней медицины, 2013
In this article you can find main stages of development of nephrology in first half of XX century in Rostov aria. Information about professors, which work was concentrated on nephrology pathology provided in article. Among them: Z.V.
М. М. Батюшин   +1 more
doaj   +1 more source

Factor Structure, Internal Consistency, and Measurement Invariance of the Eating Pathology Symptoms Inventory (EPSI) in Transgender and Gender‐Diverse Adults

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective This study aimed to examine the psychometric properties, including factor structure, internal consistency, and measurement invariance of the Eating Pathology Symptoms Inventory (EPSI) in a large national sample of transgender and gender‐diverse (TGD) adults. Method The sample consisted of 2098 TGD adults—including transgender men (n =
Jason M. Nagata   +10 more
wiley   +1 more source

Role of selenium in the pathophysiology of cardiorenal anaemia syndrome

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 770-780, April 2025.
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) have multiple bidirectional mechanisms, and anaemia is one of the critical factors that are associated with the progression of the two disorders [referred to as cardiorenal anaemia syndrome (CRAS)].
Shigeyuki Arai   +2 more
wiley   +1 more source

Nephrology in China

open access: yesHong Kong Journal of Nephrology, 2000
AbstractNephrology work was first introduced in China in the late 50s. Nephrology group in department of medicine then emerged in several high-ranked hospitals in metropolises like Beijing, Shanghai, Guangzhou, Shenyang, etc at that time. Renal biopsy and peritoneal dialysis in China was started in early 60s, when the development of nephrology in these
openaire   +2 more sources

N‐terminal pro‐brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 848-858, April 2025.
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi   +4 more
wiley   +1 more source

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy